Business Context and Reporting Period
Company: Brookdale Senior Living Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2006
Business Overview: Brookdale operates senior living facilities providing independent living, assisted living, Alzheimer's care, and skilled nursing services. As of September 30, 2006, the company operated 545 facilities in 35 states with a capacity of over 51,000 units/beds. The quarter was defined by the completion of the merger with American Retirement Corporation (ARC) on July 25, 2006, making Brookdale the largest operator of senior living facilities in the U.S. by capacity.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sept 30, 2006 |
Nine Months Ended Sept 30, 2006 |
|---|---|---|
| Total Revenue | $387,043 | $877,653 |
| Net Loss | $(31,145) | $(70,730) |
| Loss Per Share (Basic/Diluted) | $(0.34) | $(0.96) |
| Operating Cash Flow | N/A | $53,677 |
| Total Assets | $4,655,656 | N/A |
| Total Debt (Long-term + Current) | $1,724,242 | N/A |
| Cash and Cash Equivalents | $100,260 | N/A |
| Occupancy Rate | 91.4% | N/A |
Note: Revenue is primarily derived from resident fees (99.6%). Approximately 92% of resident fees for the quarter were from private pay sources.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 85.0% for the three months and 52.0% for the nine months ended September 30, 2006, compared to the prior year periods. This growth is primarily attributable to the ARC Merger and other significant acquisitions (e.g., Wellington, SALI, AEW portfolios).
- Net Loss Expansion: Net loss increased to $31.1 million for the quarter (from $18.9 million) and $70.7 million for the nine months (from $26.5 million). The increase is driven by higher depreciation and amortization ($47.1 million increase for the quarter), increased interest expense due to acquisition debt, and integration costs.
- Balance Sheet Expansion: Total assets more than doubled from $1.7 billion to $4.7 billion, and total debt increased from $754 million to $1.7 billion to fund acquisitions.
- Depreciation & Amortization: Increased 341.4% for the quarter and 307.0% for the nine months due to the step-up in asset basis from acquisitions and the ARC Merger.
Guidance, Outlook, and Risks
Management Commentary & Outlook: Management expects to generate net losses under GAAP in the near term due to increased depreciation, amortization, interest, and integration costs associated with the ARC Merger. The company plans to grow through organic expansion, acquisitions, and the realization of economies of scale. They anticipate maintaining or increasing occupancy levels (currently 91.4%) and expanding ancillary services (therapy, home health).
Risks and Contingencies:
- Integration Risk: Successfully integrating ARC's 83 facilities and 10,800+ employees is a significant undertaking; failure could adversely affect operations.
- Reimbursement Risk: The company expects to rely more on government reimbursement (Medicare/Medicaid) for therapy services. Changes in reimbursement policies or limits could adversely affect results.
- Market Risk: Approximately $1.1 billion of debt and lease payments are subject to floating interest rates, though the company has hedged a significant portion via interest rate swaps.
- Liquidity: The company reported negative working capital of $253.1 million, largely due to the classification of refundable entrance fees as current liabilities. Management expects entrance fee sales to offset refunds.
- Legal Proceedings: Two legal actions regarding the 2004 sale of facilities to Ventas are pending, with plaintiffs seeking damages in excess of $100 million per count. The company intends to vigorously defend these actions.
Investor Verification Checklist
- ARC Integration Progress: Verify the timeline and cost of integrating ARC facilities and the realization of projected synergies.
- Debt Covenants: Confirm continued compliance with financial covenants, particularly those measuring facility operating income against debt service.
- Occupancy Trends: Monitor occupancy rates across the new portfolio to ensure they meet the 91.4% benchmark and support revenue projections.
- Reimbursement Policy Changes: Track legislative changes regarding Medicare therapy service limits and their impact on ancillary revenue.
- Legal Exposure: Review updates on the Ventas-related litigation to assess potential liability impacts.
- Capital Expenditures: Verify the funding sources for the estimated $34.6 million in planned capital improvements and development equity.